跳至主要内容
临床试验/NCT01616108
NCT01616108Unknown2 期

Bupivacaine Injection of Eye Muscles to Treat Strabismus

Smith-Kettlewell Eye Research Institute1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2012年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
120
试验地点
1
主要终点
Eye alignment

研究概览

简要总结

This study seeks to determine if bupivacaine injection of eye muscles can make them stronger and stiffer, and thereby correct the position of eyes that are turned in or mis-aligned, a condition generally termed strabismus. It seeks further to find out the different effects of various concentrations or formulations of bupivacaine, and whether addition of Botox to other eye muscles can add to the effect of bupivacaine and enhance the correction of strabismus.

详细描述

Patients eligible for inclusion in the study will be age 8 to 95 years and have an eye deviation (strabismus) that is potentially subject to surgical correction.

The eye alignment will be measured. The eye muscles may be measured by MRI. The eye will be anesthetized by eye drops. One or more eye muscles will be injected with bupivacaine. Botox® will be injected into the antagonist muscle in some cases to increase the effect of the bupivacaine.

Data on the strabismus deviation, any side effects of the drug injection, and the eye muscles as measured by MRI, will be recorded at intervals after injection. These data will be compared with the like measurements taken before injection.

The primary outcome will be the eye alignment change at 180 days. A secondary outcome will be the change in muscle size, strength, or stiffness.

For large strabismus deviations not fully corrected by a first injection, a second injection can be made. Follow-up alignment and muscle measurements will be as for the initial injection.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
8 Years 至 95 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical pattern of strabismus of 5 prism diopters or more

排除标准

  • Active eye infection

研究组 & 干预措施

Bupivacaine Injection

Experimental

Differences in concentration from 0.75% to 3.0% are compared. Differences in volume for 1.0 mL to 3.0 mL are compared. Differences in compounding with addition of epinephrine will be used and compared to plain bupivacaine.

干预措施: Bupivacaine (Drug)

结局指标

主要结局

Eye alignment

时间窗: 6 months after injection

Alignment of the two eyes as measured by prism cover test or other applicable test

次要结局

  • Percentage correction of the pre-treatment eye deviation(6 months after injection treatment)

研究者

发起方
Smith-Kettlewell Eye Research Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Alan B. Scott

Senior Scientist

Smith-Kettlewell Eye Research Institute

研究点 (1)

Loading locations...

相似试验